Clinical trial
Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2…
NCT00328536 · Ruhr University of Bochum, Other · Completed
Key facts
| NCT number | NCT00328536 |
|---|---|
| Title | Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus |
| Official title | Effects of Treatment With Omacor for 6 Weeks on Preprandial and Postprandial Endothelial Function Following a High Fat Meal in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Ruhr University of Bochum, Other |
| Collaborators | Heart and Diabetes Center North-Rhine Westfalia Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Omacor |
| Enrollment | 34 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 22, 2006 |
| Last update posted | May 8, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: